ASX-listed blood products and vaccine company CSL announced decarbonisation targets on Wednesday, with a goal of scope 1 and scope 2 emissions reduction of 40 per cent by 2030.
The target is set against a baseline of average annual emissions made across 2019-21. The 2030 targets include the intention that suppliers who contribute 67 per cent of scope 3 emissions have set scope 1 and scope 2 reduction targets.
Scope 1 or direct emissions concern sources that CSL owns or controls, and scope 2 or indirect emissions are caused indirectly, such as from purchasing electricity. Scope 3 are upstream or downstream of a company’s value chain.
CSL said scope 1 and 2 reductions would occur through four key abatement levers:
“As a scientific and data driven company, we are undertaking specific measures and analysis to ensure that we continue to set and meet the right targets for the road ahead,” said CSL Chief Financial Officer Joy Linton in a statement.
Subscribe to our free @AuManufacturing newsletter here.